Objectives Successful early intervention in rheumatoid arthritis (rA) with the aim of resetting immunological tolerance requires a clearer understanding of how specificity, cellular kinetics and spatial behaviour shape the evolution of articular t cell responses. We aimed to define initial seeding of articular Cd4 + t cell responses in early experimental arthritis, evaluating their dynamic behaviour and interactions with dendritic cells (dCs) in the inflamed articular environment. Methods Antigen-induced arthritis was used to model articular inflammation. Flow cytometry and pCr of t cell receptor (tCr) diversity genes allowed phenotypic analysis of infiltrating t cells. the dynamic interactions of t cells with joint residing dCs were visualised using intravital multiphoton microscopy. results Initial recruitment of antigen-specific t cells into the joint was paralleled by accumulation of Cd4 + t cells with diverse antigen-receptor expression and ability to produce tumour necrosis factor alpha (tnFα) and interferon gamma (IFnγ) on mitogenic restimulation. A proportion of this infiltrate demonstrated slower motility speeds and engaged for longer periods with articular dCs in vivo. Abatacept treatment did not disrupt these interactions but did reduce t cell expression of inducible costimulatory (ICoS) molecule. We also demonstrated that non-specific Cd4 + t cells could be recruited during these early articular events. conclusions We demonstrate that Cd4 + t cells engage with articular dCs supporting antigen specific t cell reactivation. this cellular dialogue can be targeted therapeutically to reduce local t cell activation.
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IntrOductIOn
Rheumatoid arthritis (RA) is a chronic inflammatory disease affecting the joints, 1 characterised by synovial inflammation, degradation of bone and cartilage, progressive loss of function and increasing disability. As RA progresses, inflammatory cells, including T cells and dendritic cells (DCs), infiltrate the synovial compartment. 2 Genome-wide association studies support a role for T cells in the pathogenesis of RA; gene polymorphisms associated with CD4 + T cell function are associated with susceptibility to RA. 3 These include HLA-DRB1, PTPN22, CD28 and CTLA-4. 2 4-6 Therapeutic targeting of T cells in RA through the use of abatacept provides evidence of their importance in disease pathogenesis. However, there is increasing interest in characterising the nature of the T cell response in early RA as therapeutics move increasingly in this direction.
Activated CD4
+ T cells are present in the inflamed joints of patients with RA and appear oligoclonal in early disease. 2 7 8 However, the specificity of these T cells, their site of original activation and how they mediate pathology remain unclear. Lymph node (LN) interactions between T cells and DCs will likely be critical for naïve T cell priming. However, similar interactions could occur within the synovium, whereby joint localised reactivation of T cells would directly contribute to pathology. We employed intravital microscopy to establish the intra-articular dynamics of CD4 + T cell interactions with DCs in the context of specificity and clonality in the early stages of experimental 'early arthritis'. 9 Measurement of inducible costimulatory (ICOS) molecule was used as an indicator of T cell engagement in cognate interactions with antigen-presenting cells and reception of costimulation via CD28; that is, they had 'seen' antigen. In addition, we evaluated the dependence of this dialogue on CD28 costimulation.
MethOds Animals
LysMGFP, 10 ovalbumin-specific OT-II 11 T cell receptor (TCR) transgenic mice, OT-II DsRed and hCD2-DsRed, 12 CD11c-YFP 13 and TEa TCR RAG2−/− mice 14 were bred inhouse. C57BL/6J and Ly5.1 mice were purchased from Harlan (Harlan, Bicester, UK). All animals were specified pathogen free and maintained under standard animal house conditions at the University of Glasgow in accordance with UK Home Office Regulations.
Induction of inflammatory arthritis
ArthritoMab antibody cocktail for C57BL/6 (MD Biosciences, Zurich, Switzerland) was used to induce collagen antibody-induced arthritis (CAIA). CD4 + T cell-dependent arthritis was induced as previously reported 9 15-19 (online supplementary figure S1A ). Abatacept or control IgG was administered at 10 mg/kg (Bristol-Myers Squibb) intraperitoneally (i.p.). 24 hours before induction of arthritis and continuing every 2 days thereafter. For treatments 6 hours prior to imaging, arthritic mice were given 50 µL of abatacept (10 mg/kg) or etanercept (sTNFR-Fc, 0.5 mg/kg, etanercept, Wyeth Pharmaceuticals, Taplow, UK) into the inflamed footpad.
Multiphoton laser scanning microscopy (MPLsM)
Mice were anaesthetised using Domitor (50 mg/ kg ketamine and 0.5 mg/kg medetomidine i.p.) and placed on a heated stage. Basic and translational research the lateral malleolus was surgically exposed prior to transfer to a warmed saline bath (online supplementary figure 3A,B) . MPLSM was carried out as previously reported. 12 Second harmonic generation (SHG) was used to orientate the tissue once under the objective (online supplementary figure S3C ). Naïve joint of LysMGFP showing SHG in blue (online supplementary figure S3D ). CAIA-inflamed joint of LysMGFP mouse showing SHG (blue) and LysMGFP expressing cells (green) (online supplementary figure S3E ). Flow cytometric analysis of leucocyte populations in both naïve and CAIA-inflamed ankle joints (online supplementary figure S3F ).
recovery of cells from tissues
Ankle joints were teased apart and the tissue digested for 25 min at 37°C in 2.5 mg/mL collagenase D (Roche/Sigma Aldrich, Dorset, UK) in Hank's Balanced Salt solution (HBSS). Samples were then homogenised using Miltenyi Tissue Dissociators and strained to obtain single cell suspensions. Popliteal lymph nodes (pLNs) were forced through Nitex mesh (Cadisch Precision Meshes) to obtain single cell suspensions. Cell suspensions were then washed in fluorescence-activated cell sorting (FACS) buffer (Phospohate-buffered-saline containing 2% fetal calf serum (FCS)) and subsequently stained for flow cytometry.
Generation of bone marrow-derived dendritic cells (BMdcs)
Bone marrow from C57BL/6 mice was cultured in granulocyte-monocyte colony-stimulating factor (GM-CSF) conditioned medium as previously described. 20 After 6 days, BMDCs were cultured ±OVA (100 µg/mL) for 2 hours before maturation overnight with the addition of Escherichia coli 055:B5 LPS (100 ng/ mL) (Sigma-Aldrich). BMDCs were then washed in fresh medium and cocultured with T cells isolated from joint draining LN. + T cells were isolated using a FACS Aria IIU (BD Biosciences, Oxford, UK) and cocultured with BMDC at a 1:10 ratio for 72 hours at 37°C and 5% CO 2 . Intracellular cytokine staining was performed on cells isolated from joints and draining LNs using anti-IFNγ (XMG1.2) and anti-TNFα (MP6-XT22) following stimulation with either ovalbumin (OVA) 323-339 (0.5 µg/mL) or phorbol myristate acetate (PMA) (10 ng/mL) and ionomycin (500 ng/mL) for 4 hours in the presence of brefeldin A. Cells were acquired on an LSRII (BD Biosciences) and data analysed using FlowJo software (TreeStar version 7.6.5, Ashland, Oregon, USA).
Flow cytometry

tcr Vβ repertoire clonality
Vβ complementarity determining region 3 (CDR3) clonality was assessed using SuperTCRExpress (BioMed Immunotech, Tampa, Florida, USA) on endogenous CD4
+ T cells sorted from inflamed joints and pLNs using the BD FACs ARIAIII. Sorted cells were lysed, and the RNA extractions, cDNA synthesis and PCR were performed as per the manufacturer's instructions. PCR products were run on a 4% agarose gel and visualised on a GelDoc system (BioRad, Hertfordshire, UK).
statistics
Data are shown as mean±SD. Groups were compared using one-way analysis of variance or unpaired Student's t-test. Specific tests and significance levels are stated in the appropriate figure legends. Using data from previous studies, 12 17 we estimated that a minimum of three animals per time point/group would provide 80% power to detect significant differences (P<0.05) in numbers of T cells induced following antigen challenge versus carrier alone. Statistical analysis of results was performed using Prism V/6 (GraphPad, La Jolla, CA, USA). 
CD62L
lo/neg and produced TNFα and IFNγ following ex vivo stimulation with PMA/ ionomycin ( figure 1C,D) . Notably, endogenous CD4 + T cells from pLNs only produced TNFα on restimulation, suggesting that subsequent reactivation in the target tissue contributed to further differentiation allowing production of IFNγ (figure 1E). We tested the possibility that a proportion of these endogenous T cells may be specific for OVA, having been primed in response to immunisation with ovalbumin/complete Freund's adjuvant (OVA/CFA), used to maintain the transferred OT-II cells. T cells were FACS sorted from inflamed joints and pLNs for coculture with OVA-pulsed BMDCs. The very low numbers of T cells recovered from the inflamed joint proved prohibitive to performing a robust analysis. However, T cells sorted from the pLN showed endogenous T cells did not respond to OVA-pulsed BMDCs, whereas OT-II T cells significantly increased expression of ICOS and CD44 (online supplementary figure S2A ). In addition, ex vivo stimulation of unfractioned cells with OVA [323] [324] [325] [326] [327] [328] [329] [330] [331] [332] [333] [334] [335] [336] [337] [338] [339] revealed that OT-II T cells from inflamed joints and pLNs were able to respond, whereas the endogenous T cells were not (online supplementary figure S2B-E). Thus, while the specificity of these cells remains unknown, the majority are unlikely to be specific for the immunodominant epitope of the inciting antigen.
t cells and dc undergo long-lived interactions in the joint
Having established the recruitment kinetics of CD4 + T cells into the joint, we next visualised their behaviour using intravital multiphoton laser scanning microscopy (MPLSM) and lineage-specific fluorescent reporter mice (online supplementary figure S3 , supplementary movie S1). Following periarticular injection of HAO, a rare population of slow moving and stationary OT-II DsRed articular T cells were consistently observed (figure 2A, movie 1). Their typical behavioural parameters, namely, low speed, displacement rate and meandering index (figure 2C-E) were consistent with recognition of cognate antigen and consequent local activation. [21] [22] [23] This was reflected in the proportion of OT-II cells interacting with fluorescent DCs for longer than 10 min (figure 2F). Clustering of CD11c-YFP cells was also observed around tendons and the joint capsule.
To investigate the behaviour of infiltrating endogenous T cells, we crossed CD11c-YFP mice to intact hCD2-DsRed mice (CD11c-YFPxDsRed), allowing analysis of endogenous T cell interactions. Induction of articular inflammation resulted in recruitment of endogenous T cells to the joint (figure 2B, movie 2); these T cells exhibited a broader range of speeds, displacement rate and meandering index than the monoclonal antigen-specific OT-II population ( figure 2C-E) . Notably, some endogenous T cells displayed behaviour consistent with recognition of antigen and activation, moving slowly and remaining in contact with CD11c + cells for longer than 10 min ( figure 2F ). In parallel, many cells exhibited scanning behaviour, moving quickly from DC to DC, only contacting for short periods of less than 5 min (figure 2F). Thus, OT-II and a subpopulation of endogenous T cells interact with CD11c + cells within the inflamed articular environment in a manner consistent with antigen recognition and activation. 
Basic and translational research
Heterogeneity in motility of endogenous CD4 + T cells likely arises from diversity of antigen specificity. Given the evidence of broader autoreactive responses in this model, 9 15-17 19 and in patients with RA, 1 it seemed unlikely that a monoclonal T cell clone would dominate the inflammatory infiltrate. Therefore, in the absence of information regarding the target antigens of the endogenous T cells, we probed TCR use as an indicator of diversity among articular endogenous CD4 + T cells. By performing Vβ CDR3 clonality analyses, we were able to assess whether there was selective accumulation of few or multiple T cell clones. CD4 + T cells from naïve LN displayed diverse Vβ usage consistent with multiple (poly)clonality (online supplementary figure S4A ). Diversity was also broad in LNs draining the inflamed site-all Vβ were expressed with the exception of Vβ13 (online supplementary figure S4B) . By contrast, when articular T cells were examined, although the majority of Vβ chains were represented, only one or two CDR3 clones were identified per Vβ used (online supplementary figure S4C ). While the reduced clonality of Vβ use by the joint infiltrating CD4 + T cell population implies a role for antigen, the number of Vβ chains present may also explain the heterogeneity in behaviour seen in our imaging studies.
cd4 + t cells of irrelevant specificity can be recruited to the inflamed joint
To assess recruitment of effector/memory CD4 + T cells of unrelated/irrelevant antigen specificity, we adoptively transferred Th1 polarised TEa TCR transgenic CD4 + T cells (specific for Eα 52 absence or presence of their cognate antigen (HAO or HAO+Eα, respectively). Induction of arthritis recruited Th1 OT-II into the joint as expected; however, a significant population of TEa Th1 cells were also detected ( figure 3A,B) . Induction of arthritis with HAO and Eα 52-68 (HAO+Eα) did not significantly increase numbers of TEa in the inflamed tissue ( figure 3A,B) but was required for their upregulation of ICOS molecule expression ( figure 3C,D) and expansion of TEa in the pLN ( figure 3E,F) . Thus, the presence of a diverse TCR repertoire and the observation that a proportion of T cells continually exhibit scanning behaviour at the inflamed site could therefore be explained by recruitment of antigen experienced cells of an irrelevant antigen specificity.
Abatacept has no immediate impact on t cell/dc interactions in the inflamed joint
As well as its clinical success, 24 abatacept is also effective in murine models of disease. [25] [26] [27] Abatacept, a CTLA4-Ig fusion protein, targets one of the most important costimulators of T cell activation, blocking binding of T cell CD28 to CD80/CD86 on antigen presenting cells (APCs). [28] [29] [30] Previously we reported abatacept inhibition of pathology in our arthritis model 18 and the priming of LN T cells. 31 We extended these studies to determine the effect of abatacept on the intra-articular T cell response. Mice were treated with abatacept 1 day prior to HAO challenge and then on day 1 and day 3 postchallenge. To assess whether abatacept could have a more immediate impact on T cell/DC communication, a single administration of drug was given 6 hours prior to tissue harvesting. Abatacept treatment, either throughout or 6 hours prior to harvest, resulted in reduced accumulation of endogenous T cells in the joint ( figure 4A,B) but did not impact on OT-II articular accumulation ( figure 4A,C) . A failure to prime endogenous T cells in the pLN was found to underpin their failed accumulation in the joint (online supplementary figure S5 ). Although abatacept treatment did not significantly alter OT-II proportions in the joint draining LNs, it did prevent the upregulation of ICOS (online supplementary figure S6 ). Abatacept treatment also impacted on reactivation of endogenous and donor T cells in the joint evidenced as lower ICOS expression, even when given 6 hours prior to harvesting of cells ( figure 4D,E respectively) .
Consistent with the flow cytometry data, MPLSM of PBS challenged joints revealed few T cells or DCs, whereas a large population of endogenous T cells was observed after HAO challenge ( figure 5A, movie 3 ). Abatacept treatment throughout reduced endogenous T cell infiltration of inflamed joints (figure 5A, movie 3), consistent with our flow data. T cells that were observed exhibited reduced speed (figure 5B). The displacement rate (figure 5C), directionality of their movement (meandering index, figure 5D ) and interaction time with DCs (figure 5E) appeared to be unaffected. Previous studies show that motility is influenced by numerous extrinsic factors (reviewed in ref 32) . Published data suggest that the availability of such factors is altered/limited in the reduced inflammatory environment postabatacept treatment. 18 Abatacept treatment 6 hours prior to imaging did not impact on T cell speed, displacement rate, meandering index or interaction times with articular DCs ( figure 5A-E, movie 3) . Anti-TNF (etanercept), given as an additional control 6 hours prior to imaging, similarly had no impact on the behaviour of T cells in the joint ( figure 5A-E, movie 3) . Although abatacept did not alter endogenous T cell/DC articular interactions, even 6 hours of localised exposure was sufficient to reduce expression of ICOS, indicative of continued dialogue between APC and T cell in the inflamed joint. Abatacept is therefore able to affect the re-activation of T cells within the inflamed joint itself.
dIscussIOn
We present the first examination of the dynamics of T cell recruitment and interactions in the articular environment. Using a model of early articular inflammation, we find that recruitment of a small population of antigen-specific CD4 + T cells is paralleled by influx of a larger oligoclonal CD4 + T cell population, a significant proportion of which engages with DCs in a 
Basic and translational research
manner consistent with recognition of cognate antigen. Signalling through CD28 was not required for ongoing articular interactions but was critical for full activation of CD4 + T cells in the joint. These findings enhance our fundamental understanding of the location and dynamics of the cellular interactions that control the development of articular inflammation and will be informative for future studies in clinical RA examining the evolution of articular T cell responses.
Genetic studies have implicated CD4 + T cells in the pathogenesis of RA. [2] [3] [4] [5] [6] Consistent with this, our model displayed recruitment of immune system cells, including neutrophils, macrophages, B cells, DCs and, crucially, CD4 + T cells. These T cells displayed an antigen-experienced phenotype with the potential to produce pro-inflammatory TNFα and IFNγ. As expected, an increased proportion of CD4 + T cells capable of producing TNFα were found in the LN draining the inflamed joint. It has long been known that T cells in somatic tissues have a memory phenotype, and T cells in the inflamed joint also have an antigen experienced phenotype. However, the role of antigen in the recruitment, retention or activation of memory T cells remains unclear. To address this, we imaged T-DC interactions in the joint.
The dynamics of T cell interactions with DC have been characterised using in vivo imaging and revealed particular behaviours indicative of certain outcomes. For example, activation of T cells in LN occurs with three phases: the first (typically the initial 8 hours of antigen exposure) is characterised by transient interactions (<5 min); the second, 8-20 hours after exposure to antigen, is characterised by long lived T cell/DC interactions (>10 min) reflecting recognition of cognate antigen and costimulation, underpinning priming of the T cell 21 22 33 ; after ~48 hours, T cells recover motility, and subsequent interactions with DCs are short. Equally, these interactions can also impact on T cell differentiation 12 and even tolerance. 23 34 Our studies directly demonstrate stable interactions between endogenous CD4 + T cells and DCs in the inflamed joint consistent with recognition of specific antigen. These interactions likely underpin our observation that TNFα producing T cells in the joint coexpressed IFNγ unlike their counterparts in the joint draining LN. A similar 'two hit' theory has already been proposed for IL-4 production. 35 36 Although the specificity of T cells in RA joints remains unclear, diversity in TCR expression by synovial T cells is reduced, indicating their selective accumulation. [37] [38] [39] [40] Notably, comparable clonal responses are detected in healthy siblings of RA sufferers. 41 Thus, changes in clonality of the response are likely to occur early in disease and reflect disease status. Indeed, selected Vβ clonal expansion seen in peripheral blood of patients with RA 42 is reduced in the face of successful anti-TNFα therapy, 43 indicating alterations in repertoire can inform as to responsiveness to therapeutic intervention. Endogenous T cells infiltrating joints 
in our model exhibited reduced Vβ CDR3 repertoire diversity, consistent with the oligoclonal nature of human RA synovial T cells. 39 44-46 The similarity in clonal responses in the joint and draining LN also supports the hypothesis that T cell activation and clonal expansion occurs in secondary lymphoid organs prior to migration and accumulation in the joint. Given the propensity for autoreactivity arising in the endogenous CD4 + T cell compartment in our model 9 and the observation of sustained interactions with DCs in the inflamed joint, our data support a model where autoreactive T cells may constitute a small but significant population of articular infiltrating T cells and that cognate interactions with DCs would support their activation/ proliferation in response to local antigen. 47 48 As some endogenous T cells did not undergo interactions with DC in the inflamed joint and the TCR usage analysis demonstrated an oligoclonal response, we tested whether figure S1A ). In addition, mice were either treated throughout with abatacept (Aba) (given 24 hours prior to challenge and every 2 days thereafter) or 6 hours prior to imaging. MPLSM of ankle joints was performed on day 4 following challenge. In addition, one group received etanercept (Etan) given 6 hours prior to imaging. (A) Representative MPLSM images showing CD11c + cells (yellow), endogenous T cells (red) and SHG from joint capsule and tendon (blue). Cell tracking was performed to determine T cell (B) speed, (C) displacement rate, (D) meandering index and (E) duration of contact with CD11c + cells using Volocity image analysis software for three fields of view and three animals. Data show the mean with points representing individual cells. Data are representative of two independent experiments. Scale bars represent 50 µm. HAO, heat-aggregated ovalbumin; MPLSM, multiphoton laser scanning microscopy; SHG, second harmonic generation.
activated/memory T cells of irrelevant antigen specificity could be recruited to the inflamed joint. Indeed, a range of viral and bacterial T cell specificities have been identified in RA synovial tissue, 49 and consistent with this, we directly demonstrated that irrelevant-specificity CD4 + T cells can be recruited to the inflamed joint independently of cognate antigen. Such memory T cells may be activated by the inflammatory environment as reported by Brennan 50 51 and others [52] [53] [54] in the instance of cytokine-activated T cells. While recruitment of irrelevant specificity T cells was not dependent on cognate antigen, the latter was required for upregulation of ICOS, stressing the importance of cognate Tcell-DC interaction in the inflamed joint for full T cell activation.
As we found antigen-specific, oligoclonal and unrelated T cells in the joint, we examined whether a current therapeutic targeting T cell-DC interactions affected these cells in the joint or draining LN. While abatacept did not directly inhibit the ability of T cells and DCs to interact in the inflamed joint, the diminished ability of these T cells to upregulate ICOS suggested a failure in their activation. Thus, in addition to inhibiting priming of potentially autoreactive T cells in the joint draining LN, abatacept influences the quality of T cell-DCl interactions directly in the inflamed joint.
In conclusion, our findings demonstrate that T cells make cognate interactions with DCs in the inflamed joint. Recruitment of a small number of inciting antigen-specific T cells into the joint environment is paralleled by a larger oligoclonal population of pro-inflammatory CD4 + T cells, a proportion of which interact with DCs in a manner consistent with recognition of cognate antigen. We also demonstrate that T cells of irrelevant specificity can enter the joint. However, recognition of cognate antigen with costimulation is necessary for full activation in the articular environment.
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